# A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects

> **NCT05316428** · PHASE1 · COMPLETED · sponsor: **Vigonvita Life Sciences** · enrollment: 19 (actual)

## Conditions studied

- Alcohol
- Phosphodiesterase Inhibitor
- Erectile Dysfunction

## Interventions

- **DRUG:** TPN171H tablet plus alcohol
- **OTHER:** alcohol
- **DRUG:** TPN171H tablet

## Key facts

- **NCT ID:** NCT05316428
- **Lead sponsor:** Vigonvita Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-24
- **Primary completion:** 2022-04-02
- **Final completion:** 2022-04-06
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2022-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05316428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05316428, "A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05316428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*